ID

19252

Descripción

A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.; ODM derived from: https://clinicaltrials.gov/show/NCT00077727

Link

https://clinicaltrials.gov/show/NCT00077727

Palabras clave

Versiones (1)
  1. 15/12/16 15/12/16 -
Subido en

15 de diciembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00077727

Inglés

Eligibility Schizophrenia NCT00077727

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of schizophrenia present for at least 1 year, and has not returned to his/her level of functioning before the disease, with a brief psychiatric rating scale score of 30 to 60 (inclusive), and cognitive impairment as determined by scores from neuropsychological tests and subtests
Descripción

Schizophrenia disease length Brief Psychiatric Rating Scale | Impaired cognition Neuropsychological Tests Score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0872146
UMLS CUI [1,3]
C0029941
UMLS CUI [2,1]
C0338656
UMLS CUI [2,2]
C0027902
UMLS CUI [2,3]
C0449820
nicotine user with a minimum intake equivalent to 5 cigarettes per day
Descripción

Tobacco use Number of cigarettes per day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C3694146
on a stable dose of allowed atypical antipsychotic medication (risperidone [either oral or consta], olanzapine, quetiapine, ziprasidone, or aripiprazole) alone or in combination, for at least 30 days before screening, and deemed able to continue on the same dose
Descripción

Atypical antipsychotic Dose Stable | Risperidone Oral Product | Risperidone | olanzapine | quetiapine | ziprasidone | aripiprazole

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1276996
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C1319760
UMLS CUI [3]
C0073393
UMLS CUI [4]
C0171023
UMLS CUI [5]
C0123091
UMLS CUI [6]
C0380393
UMLS CUI [7]
C0299792
women patients must be postmenopausal, surgically sterile, or using appropriate contraception before entry and throughout the study, and have a negative pregnancy test at screening
Descripción

Postmenopausal state | Female Sterilization | Gender Contraceptive methods | Gender Pregnancy test negative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0015787
UMLS CUI [3,1]
C0079399
UMLS CUI [3,2]
C0700589
UMLS CUI [4,1]
C0079399
UMLS CUI [4,2]
C0427780
able to read, write, and understand english, and has no limitations in communication skills that would prevent him/her from completing the cognitive tests used in this study.
Descripción

Able to read English Language | Able to write English Language | Comprehension English Language | Communication skills Adequate | Tests Cognitive Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0586740
UMLS CUI [1,2]
C0376245
UMLS CUI [2,1]
C0584993
UMLS CUI [2,2]
C0376245
UMLS CUI [3,1]
C0233733
UMLS CUI [3,2]
C0376245
UMLS CUI [4,1]
C0870313
UMLS CUI [4,2]
C0205411
UMLS CUI [5,1]
C0392366
UMLS CUI [5,2]
C1516691
UMLS CUI [5,3]
C0205197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previously enrolled in a galantamine hydrobromide study
Descripción

Study Subject Participation Status | galantamine hydrobromide Clinical Trial

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0949312
UMLS CUI [2,2]
C0008976
any clinically significant uncontrolled medical illness (such as peptic ulcer disease
Descripción

Illness Clinical Significance Uncontrolled | Peptic Ulcer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C0205318
UMLS CUI [2]
C0030920
urinary tract obstruction
Descripción

Urinary tract obstruction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0178879
or neurologic, cardiac, hepatic, renal, metabolic, or endocrine disturbances)
Descripción

nervous system disorder | Heart Diseases | Liver diseases | Kidney Diseases | Metabolic Diseases | Endocrine System Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0018799
UMLS CUI [3]
C0023895
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0025517
UMLS CUI [6]
C0014130
history of severe asthma
Descripción

Severe asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0581126
any history of epilepsy or convulsions, except for febrile convulsions during childhood
Descripción

Epilepsy | Convulsions | Febrile Convulsions Childhood

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0014544
UMLS CUI [2]
C4048158
UMLS CUI [3,1]
C0009952
UMLS CUI [3,2]
C0231335
history of cancer within the past year, except for treated basal cell carcinoma, or any history of prolactin-dependent breast cancer
Descripción

Malignant Neoplasms | Basal cell carcinoma Treated | Breast Carcinoma Prolactin Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0678222
UMLS CUI [3,2]
C0033371
UMLS CUI [3,3]
C0851827
Volver a la parte superior de la página

Similar models

Eligibility Schizophrenia NCT00077727

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia disease length Brief Psychiatric Rating Scale | Impaired cognition Neuropsychological Tests Score
Item
diagnosis of schizophrenia present for at least 1 year, and has not returned to his/her level of functioning before the disease, with a brief psychiatric rating scale score of 30 to 60 (inclusive), and cognitive impairment as determined by scores from neuropsychological tests and subtests
boolean
C0036341 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0029941 (UMLS CUI [1,3])
C0338656 (UMLS CUI [2,1])
C0027902 (UMLS CUI [2,2])
C0449820 (UMLS CUI [2,3])
Tobacco use Number of cigarettes per day
Item
nicotine user with a minimum intake equivalent to 5 cigarettes per day
boolean
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
Atypical antipsychotic Dose Stable | Risperidone Oral Product | Risperidone | olanzapine | quetiapine | ziprasidone | aripiprazole
Item
on a stable dose of allowed atypical antipsychotic medication (risperidone [either oral or consta], olanzapine, quetiapine, ziprasidone, or aripiprazole) alone or in combination, for at least 30 days before screening, and deemed able to continue on the same dose
boolean
C1276996 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1319760 (UMLS CUI [2])
C0073393 (UMLS CUI [3])
C0171023 (UMLS CUI [4])
C0123091 (UMLS CUI [5])
C0380393 (UMLS CUI [6])
C0299792 (UMLS CUI [7])
Postmenopausal state | Female Sterilization | Gender Contraceptive methods | Gender Pregnancy test negative
Item
women patients must be postmenopausal, surgically sterile, or using appropriate contraception before entry and throughout the study, and have a negative pregnancy test at screening
boolean
C0232970 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0079399 (UMLS CUI [4,1])
C0427780 (UMLS CUI [4,2])
Able to read English Language | Able to write English Language | Comprehension English Language | Communication skills Adequate | Tests Cognitive Completion
Item
able to read, write, and understand english, and has no limitations in communication skills that would prevent him/her from completing the cognitive tests used in this study.
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0584993 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0233733 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
C0870313 (UMLS CUI [4,1])
C0205411 (UMLS CUI [4,2])
C0392366 (UMLS CUI [5,1])
C1516691 (UMLS CUI [5,2])
C0205197 (UMLS CUI [5,3])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status | galantamine hydrobromide Clinical Trial
Item
previously enrolled in a galantamine hydrobromide study
boolean
C2348568 (UMLS CUI [1])
C0949312 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
Illness Clinical Significance Uncontrolled | Peptic Ulcer
Item
any clinically significant uncontrolled medical illness (such as peptic ulcer disease
boolean
C0221423 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0030920 (UMLS CUI [2])
Urinary tract obstruction
Item
urinary tract obstruction
boolean
C0178879 (UMLS CUI [1])
nervous system disorder | Heart Diseases | Liver diseases | Kidney Diseases | Metabolic Diseases | Endocrine System Diseases
Item
or neurologic, cardiac, hepatic, renal, metabolic, or endocrine disturbances)
boolean
C0027765 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0025517 (UMLS CUI [5])
C0014130 (UMLS CUI [6])
Severe asthma
Item
history of severe asthma
boolean
C0581126 (UMLS CUI [1])
Epilepsy | Convulsions | Febrile Convulsions Childhood
Item
any history of epilepsy or convulsions, except for febrile convulsions during childhood
boolean
C0014544 (UMLS CUI [1])
C4048158 (UMLS CUI [2])
C0009952 (UMLS CUI [3,1])
C0231335 (UMLS CUI [3,2])
Malignant Neoplasms | Basal cell carcinoma Treated | Breast Carcinoma Prolactin Dependent
Item
history of cancer within the past year, except for treated basal cell carcinoma, or any history of prolactin-dependent breast cancer
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0678222 (UMLS CUI [3,1])
C0033371 (UMLS CUI [3,2])
C0851827 (UMLS CUI [3,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial